Pages that link to "Q24535576"
Jump to navigation
Jump to search
The following pages link to Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation (Q24535576):
Displaying 50 items.
- Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1 (Q21136155) (← links)
- The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy (Q24312951) (← links)
- Phosphorylation of Ser357 of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-delta on insulin action in skeletal muscle cells (Q24315127) (← links)
- Endoplasmic reticulum stress and the inflammatory basis of metabolic disease (Q24633352) (← links)
- mTOR signaling in growth control and disease (Q24634174) (← links)
- Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1 (Q24645183) (← links)
- Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis (Q24670558) (← links)
- Over-nutrition and metabolic cardiomyopathy (Q27000683) (← links)
- Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle (Q27009396) (← links)
- Metabolic benefits of resistance training and fast glycolytic skeletal muscle (Q27687459) (← links)
- Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives (Q28071388) (← links)
- The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins (Q28088661) (← links)
- Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 (Q28272571) (← links)
- Computational modeling and analysis of insulin induced eukaryotic translation initiation (Q28477922) (← links)
- Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2 (Q28511429) (← links)
- Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling (Q28513222) (← links)
- Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis (Q28551227) (← links)
- Ras homolog, mTORC1 binding (Q28562868) (← links)
- Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage (Q28583646) (← links)
- Leucine signaling in the pathogenesis of type 2 diabetes and obesity (Q29543116) (← links)
- Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 (Q29617097) (← links)
- Insulin resistance without elevated mammalian target of rapamycin complex 1 activity in muscles of mice fed a high-fat diet (Q30417125) (← links)
- Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins (Q30438876) (← links)
- Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation (Q33556119) (← links)
- Successful weight loss surgery improves eating control and energy metabolism: a review of the evidence (Q33557084) (← links)
- Loss of hepatic DEPTOR alters the metabolic transition to fasting (Q33600500) (← links)
- Dynamic switch of negative feedback regulation in Drosophila Akt-TOR signaling (Q33619056) (← links)
- Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice (Q33656497) (← links)
- Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage (Q33750671) (← links)
- Short term elevation in dietary protein intake does not worsen insulin resistance or lipids in older adults with metabolic syndrome: a randomized-controlled trial (Q33904759) (← links)
- Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma (Q33918399) (← links)
- Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation (Q34049893) (← links)
- Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo (Q34080562) (← links)
- Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes (Q34102206) (← links)
- IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects (Q34132583) (← links)
- DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity. (Q34293348) (← links)
- Regulation of mTORC1 and its impact on gene expression at a glance (Q34342717) (← links)
- TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists (Q34391710) (← links)
- PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent (Q34460797) (← links)
- Metformin and sex: Why suppression of aging may be harmful to young male mice (Q34554303) (← links)
- Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells (Q34600369) (← links)
- Caloric restriction promotes the reserve of follicle pool in adult female rats by inhibiting the activation of mammalian target of rapamycin signaling (Q34766166) (← links)
- An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism (Q34800387) (← links)
- The PTEN-PI3K pathway: of feedbacks and cross-talks (Q34828662) (← links)
- Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum (Q34894537) (← links)
- Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance. (Q34974398) (← links)
- Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma (Q34977124) (← links)
- Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways (Q34998025) (← links)
- Frontier of epilepsy research - mTOR signaling pathway (Q35014198) (← links)
- AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. (Q35103810) (← links)